Correction to: Surfactant protein A as a biomarker of outcomes of anti-fibrotic drug therapy in patients with idiopathic pulmonary fibrosis.

BMC Pulm Med

Department of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, 1-37, South 1-West 16, Chuo-ku, Sapporo, Hokkaido, 060-8543, Japan.

Published: May 2020

Following publication of the original article [1], the authors have flagged that there is an error in Fig. 3.

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206697	PMC
http://dx.doi.org/10.1186/s12890-020-1118-x	DOI Listing

Publication Analysis

correction surfactant

surfactant protein

protein biomarker

biomarker outcomes

outcomes anti-fibrotic

anti-fibrotic drug

drug therapy

therapy patients

patients idiopathic

idiopathic pulmonary

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!